ETF offers access to biotechnology and pharmaceutical companies from the US
Sign up for our weekly Newsletter and receive the latest ETF and ETC news. Click here to register for your free copy
A new exchange traded fund issued by iShares has been tradable on Xetra and Börse Frankfurt since Thursday.
Name: iShares NASDAQ US Biotechnology UCITS ETF
Asset class: equity index ETF
Ongoing charges p.a.: 0.35 percent
Distribution policy: accumulating
Reference index: NASDAQ Biotechnology Index
The iShares NASDAQ US Biotechnology UCITS ETF enables investors to participate in the performance of biotechnology and pharmaceutical companies from the US. The index components must be listed on NASDAQ and meet set admission criteria on market capitalisation and liquidity. The maximum weighting of an index component is eight percent. In addition, a maximum of five index components are permitted to reach this limit.